International interest creates booming growth rates for contract research
Contract research organizations all over the world experience unprecedented growth rates, especially because more and more drug groups bring in external innovation from biotech companies.
There is plenty of work for the world's contract research organizations (CROs) these years, and many companies present two-digit growth rates. In five years, the global CRO sector's estimated value has increased from USD 25 billion to USD 37 billion, and future expectations for the industry are sky-high.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Klifo expands with acquisition of German company
For abonnenter
Danish CROs benefit from life science growth spurt
For abonnenter
Gubra CEO aims for more big pharma partnerships
For abonnenter
